Lanfermeijer Josien, van de Ven Koen, Hendriks Marion, van Dijken Harry, Lenz Stefanie, Vos Martijn, Borghans José A M, van Baarle Debbie, de Jonge Jørgen
Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3720 BA Bilthoven, The Netherlands.
Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Vaccines (Basel). 2024 Apr 15;12(4):419. doi: 10.3390/vaccines12040419.
To protect older adults against influenza A virus (IAV) infection, innovative strategies are imperative to overcome the decrease in protective immune response with age. One approach involves the boosting of CD8+ T cells at middle age that were previously induced by natural infection. At this stage, the immune system is still fit. Given the high conservation of T-cell epitopes within internal viral proteins, such a response may confer lasting protection against evolving influenza strains at older age, also reducing the high number of influenza immunizations currently required. However, at the time of vaccination, some individuals may have been more recently exposed to IAV than others, which could affect the T-cell response. We therefore investigated the fundamental principle of how the interval between the last infection and booster immunization during middle age influences the CD8+ T-cell response. To model this, female mice were infected at either 6 or 9 months of age and subsequently received a heterosubtypic infection booster at middle age (12 months). Before the booster infection, 6-month-primed mice displayed lower IAV-specific CD8+ T-cell responses in the spleen and lung than 9-month-primed mice. Both groups were better protected against the subsequent heterosubtypic booster infection compared to naïve mice. Notably, despite the different CD8+ T-cell levels between the 6-month- and 9-month-primed mice, we observed comparable responses after booster infection, based on IFNγ responses, and IAV-specific T-cell frequencies and repertoire diversity. Lung-derived CD8+ T cells of 6- and 9-month-primed mice expressed similar levels of tissue-resident memory-T-cell markers 30 days post booster infection. These data suggest that the IAV-specific CD8+ T-cell response after boosting is not influenced by the time post priming.
为保护老年人免受甲型流感病毒(IAV)感染,必须采取创新策略来克服随着年龄增长保护免疫反应下降的问题。一种方法是在中年时增强先前由自然感染诱导产生的CD8 + T细胞。在这个阶段,免疫系统仍然健康。鉴于病毒内部蛋白中T细胞表位的高度保守性,这种反应可能为老年人抵御不断演变的流感毒株提供持久保护,同时也减少了目前所需的大量流感疫苗接种。然而,在接种疫苗时,一些个体可能比其他个体最近更频繁地接触IAV,这可能会影响T细胞反应。因此,我们研究了中年时期最后一次感染与加强免疫之间的间隔如何影响CD8 + T细胞反应的基本原理。为了对此进行模拟,雌性小鼠在6个月或9个月大时受到感染,随后在中年(12个月)时接受异源亚型感染加强免疫。在加强感染之前,6个月龄初次免疫的小鼠在脾脏和肺部的IAV特异性CD8 + T细胞反应比9个月龄初次免疫的小鼠低。与未感染的小鼠相比,两组对随后的异源亚型加强感染都有更好的保护作用。值得注意的是,尽管6个月龄和9个月龄初次免疫的小鼠之间CD8 + T细胞水平不同,但基于IFNγ反应、IAV特异性T细胞频率和库多样性,我们在加强感染后观察到了类似的反应。加强感染后30天,6个月龄和9个月龄初次免疫的小鼠肺源性CD8 + T细胞表达的组织驻留记忆T细胞标志物水平相似。这些数据表明,加强免疫后IAV特异性CD8 + T细胞反应不受初次免疫后时间的影响。